Thomas Høyer;Sophie Elisabeth Havez;Jef Fenscholdt;Xifu Liang
发明人:
Jef Fenscholdt,Thomas Høyer,Xifu Liang,Sophie Elisabeth Havez
申请号：
US13322189
公开号：
US20120101039A1
申请日:
2010.05.26
申请国别(地区):
US
年份:
2012
代理人:
摘要：
A compound of general formula I their use as calcium receptor-active compounds for the prophylaxis, treatment or amelioration of physiological disorders or diseases associated with disturbances of CaSR activity, such as hyperparathyroidism, pharmaceutical compositions comprising said compounds, methods of treating diseases with said compounds, and the use of said compounds in the manufacture of medicaments.
